Digital healthcare company Murj announced the availability of the Murj Analytics software-as-a-service (SaaS) platform for cardiac implantable electronic device (CIED) management. This new offering features powerful intelligence for cardiac device clinicians seeking to provide comprehensive population management through improved clinical, workforce and quality of care metrics.
At the 40th annual Heart Rhythm Scientific Sessions, May 8-11 in San Francisco, Acutus Medical announced the agreement to acquire Rhythm Xience Inc., and new strategic partnerships with Peerbridge Health, Cardiac Designs and MedFact. Acutus' expanded portfolio builds on the organization's mapping and visualization technology platform.
Preventice Solutions presented clinical data validating its BodyGuardian Remote Monitoring System with the BeatLogic deep learning platform at Heart Rhythm 2019, the Heart Rhythm Society’s 40th Annual Scientific Sessions, May 8-11 in San Francisco. This technology leverages machine learning and artificial intelligence (AI) for detection of atrial fibrillation (AF) and was validated using clinician adjudicated data.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Johnson & Johnson Medical Devices Companies announced the launch of Biosense Webster Inc.’s Cartonet to help electrophysiologists, hospitals, health systems, and researchers leverage and share data, with the goal of improving patient outcomes and operational efficiency in catheter ablation procedures. Announced at Heart Rhythm 2019, the Heart Rhythm Society's (HRS) 40th Annual Heart Rhythm Scientific Sessions, May 8-11 in San Francisco, Cartonet is the world’s first cloud-based networking and data analytics software solution for the field of electrophysiology, according to the company.
Johnson & Johnson Medical Devices Companies announced that Biosense Webster, Inc.’s QDot Micro catheter demonstrated safety and efficacy in achieving pulmonary vein isolation in patients with symptomatic drug-refractory paroxysmal atrial fibrillation (AF).
The Heart Rhythm Society (HRS) 2019 Annual Scientific Sessions represent an important annual event for electrophysiology ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
CardioFocus Inc. announced the presentation of results from its pivotal confirmatory study evaluating the HeartLight X3 System for the treatment of atrial fibrillation (AFib). The results, which demonstrated superior procedural times and impressive procedural outcomes, according to the company, were presented during the Heart Rhythm Society's (HRS) 40th Annual Scientific Sessions, May 8-11, 2019 in San Francisco.
BioCardia Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Avance steerable introducer product family, designed for introducing various cardiovascular catheters into the heart, including via the left side of the heart through the interatrial septum.
This is an example of how the heart's left atrial appendage (LAA) can be evaluated for thrombus and possible ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
This is an example of a carotid artery reporting module from Change Healthcare at 2018 Radiological Society of North ...
W. L. Gore & Associates Inc. (Gore) announced the U.S. Food and Drug Administration (FDA) has granted regulatory approval for commercial distribution of the Gore Tag Conformable Thoracic Stent Graft with Active Control System. The device is a thoracic endovascular aortic repair (TEVAR) solution combining new levels of control with the performance of the Conformable Gore Tag Device. The device and delivery system provide new precision and predictable patient outcomes in the endovascular repair of aneurysms, transections and Type B dissections of the descending thoracic aorta. A smaller-diameter primary delivery sleeve gives the device and system a lower profile across 10 device sizes.
Cordis, a Cardinal Health company, recently announced the full U.S. launch of its Radial 360 portfolio, offering a complete range of products to facilitate the transradial approach (TRA) for interventional cardiology procedures.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Artificial intelligence (AI) solutions provider Aidoc has been granted U.S. Food and Drug Administration (FDA) clearance for an additional product in its expanding suite of AI-based workflow orchestration solutions. The clearance is for Aidoc's Pulmonary Embolism (PE) solution that works with radiologists to flag and triage PE cases in chest computed tomography (CT) scans. The approval comes just weeks after Aidoc closed a $27 million funding round, bringing its total funding to $40 million.
May 15, 2019 — A new study shows electromechanical wave imaging is capable of localizing arrhythmias including atrial ...
May 15, 2019 — A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1] The ...